Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

pDNA/cationic lipid molecule nanoparticles

Based on

1 Patents
2013 Most recent source

Composition

1

di(Z)-octadec-9-enyl 1-(4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl) phenyl)-1-oxo-2,6,11,15-tetraazaoctadecan-18-ylphosphonate

Type Single Compound
Formula C66H119N10O5P
Role raw materials
2

pBsr2 pCpGLacZh plasmid

Type Biomolecule
Formula
Role raw materials

Properties

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information available to subscribers only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • di(Z)-octadec-9-enyl 1-(4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl) phenyl)-1-oxo-2,6,11,15-tetraazaoctadecan-18-ylphosphonate
  • pBsr2 pCpGLacZh plasmid
Product

pDNA/cationic lipid molecule nanoparticles

Hydrodynamic diameter: 161.4 - 178.2 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial